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The Binding Site of Acetylcholine Receptor as
Visualized in the X-Ray Structure of a Complex
between -Bungarotoxin and a Mimotope Peptide
AChR and exhibit high toxicity due to inhibition of AChR
function at the neuromuscular junction. Synthetic pep-
tides that bind to -BTX may serve as competitive inhibi-
tors of -BTX binding to AChR, and hence provide po-
tential lead compounds for antidotes against -BTX
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The X-ray structure of AChR has not yet been solved2 Department of Biological Chemistry
since its hydrophobic character hampers its successful3 Department of Organic Chemistry
crystallization. There have been several attempts to4 Department of Immunology
crystallize the extracellular domain of AChR  subunitWeizmann Institute of Science
and most recently, the X-ray structure of an acetylcho-Rehovot 76100
line binding protein (AChBP), a water-soluble homologIsrael
of the nicotinic AChR ligand binding domain isolated5 Department of Molecular and Cellular
from snail, has been solved (Brejc et al., 2001). The highNeurobiology
affinity and specific interaction of -BTX with AChR hasVrije Universiteit
been of considerable importance in the study of theDe Boelelaan 1087
ligand binding site of AChR. The ligand binding site of1081 HV Amsterdam
AChR is located mainly at the  subunit, in the vicinityThe Netherlands
of Cys192 and Cys193 (Kao et al., 1984; Neumann et6 Division of Molecular Carcinogenesis
al., 1985), though residues in the interface of neighboringNetherlands Cancer Institute
subunits contribute also to the binding site (ChangeuxPlesmanlaan 121
and Edelstein, 1998; Karlin and Akabas, 1995 and refer-1066 CX Amsterdam
ences cited therein). Short synthetic peptides derivedThe Netherlands
from this region of the AChR  subunit were shown to
bind -BTX (Lentz, 1995; Neumann et al., 1986a). A 12-
mer synthetic peptide corresponding to residues 185–
196 of the AChR, and encompassing the two tandemSummary
cysteines, was found to bind agonists specifically and
to inhibit the binding of -BTX to AChR with an IC50 ofWe have determined the crystal structure at 1.8 A˚ reso-
104 M (Neumann et al., 1986a, 1986b).lution of a complex of-bungarotoxin with a high affin-
Additional information on the -BTX binding site inity 13-residue peptide that is homologous to the bind-
the AChR molecule came from our previous study em-ing region of the  subunit of acetylcholine receptor.
ploying a random combinatorial phage-display peptideThe peptide fits snugly to the toxin and adopts a 
library (Balass et al., 1997). We have identified a libraryhairpin conformation. The structures of the bound pep-
lead peptide (MRYYESSLKSYPD) that binds -BTX andtide and the homologous loop of acetylcholine binding
inhibits its binding to AChR with an IC50 in the low-protein, a soluble analog of the extracellular domain of
micromolar range. This peptide contains the motifacetylcholine receptor, are remarkably similar. Their
YYXSS that is homologous to the AChR consensus motifsuperposition indicates that the toxin wraps around
YYXCC193, located at the ligand binding site. Alignmentthe receptor binding site loop, and in addition, binds
of the library lead peptide with the corresponding aminotightly at the interface of two of the receptor subunits
acid residues in AChR resulted in a 13-mer peptide cor-where it inserts a finger into the ligand binding site,
responding to residues 187–199 of the Torpedo califor-thus blocking access to the acetylcholine binding site
nica AChR (TcAChR)  subunit, which inhibits the bind-and explaining its strong antagonistic activity.
ing of -BTX to AChR with an IC50 of 106 M (Balass et
al., 1997). The structure of the complex between -BTX
and the library lead peptide has been determined usingIntroduction
2D 1H-NMR (Scherf et al., 1997). The amino acid residues
in the library lead peptide that interact with -BTX wereThe nicotinic acetylcholine receptor (AChR) is a ligand-
identified and it was shown that the bound peptidegated ion channel activated by binding of acetylcholine
adopts a loop conformation around a hydrophobic core(ACh) (for reviews see Changeux and Edelstein, 1998;
created by a side chain of Tyr197 of the peptide (pep-Karlin and Akabas, 1995). -Neurotoxins, such as -bung-
tide numbering follows the  subunit numbering—seearotoxin (-BTX), behave as competitive antagonists of
Table 1).ACh for its site (Changeux et al., 1970; Lee and Chang,
In a recent study (Kasher et al., 2001), we employed1966). They bind specifically and with high affinity to
NMR-derived structural information of the complex of
-BTX with the lead peptide (Scherf et al., 1997), along
with other structural and functional features of the AChR7 Correspondence: sara.fuchs@weizmann.ac.il
system (Barchan et al., 1995; Kachalsky et al., 1995;8 These authors contributed equally to this work.
Neumann et al., 1989), to design and prepare peptides9 Permanent address: Department of Biochemistry, University of
Sydney, N.S.W. 2006, Australia. that interact with -BTX with increased affinity. We used
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Table 1. Sequence of HAP and Related Peptides and Their Inhibition of -BTX Binding to AChR
Peptide 187 188 189 190 191 192 193 194 195 196 197 198 199 200 IC50 (M)a
Lead peptide M R Y Y E S S L K S Y P D 3.3  107
HAP W R Y Y E S S L L P Y P D 1.9  109
HAP#2 W R Y Y E S S L E P Y P D 2.0  109
HAP#3 W R Y Y E S S L D P Y P D 3.8  109
HAP#4 W R Y Y E C C L D P Y P D 1.9  109
HAP#5 W R Y Y E S S L K P Y P D 1.0  108
Muscle TCAChR W V Y Y T C C P D T P Y L D 2.6  108
187–200 (1)
Neuronal rat brain E K F Y E C C K E P Y P D 1.8  105
AChR 187–199 (7)
AChBP 182–194b S V T Y S C C P E A Y E D NDc
Identical residues in the HAP and either TcAChR 1 or rat brain 7 subunits (both of which bind -BTX) are in italics and underlined.
Residues in bold are HAP residues different from the lead peptide.
a Data are from Kasher et al. (2001).
b AChBP sequence from Smit et al. (2001).
c Not determined.
the phage-library peptide MRYYESSLKSYPD (Balass et Results and Discussion
al., 1997) as the lead peptide, and designed a new re-
The Crystal Structure of -BTX-HAPstricted combinatorial peptide library based on rational
A co-crystal of -BTX with the high affinity peptide WRY-replacement of a limited number of amino acid residues
YESSLLPYPD was grown, and designated -BTX-HAP.in the lead peptide. Several peptides that bind -BTX
This is a novel report on a crystal structure of a complexwith high affinity and inhibit its binding to TcAChR with
of -BTX with an AChR-related peptide. The refinedan IC50 in the nanomolar range have been produced
structure of -BTX-HAP contains two monomers of(Table 1). This affinity is in the range of that reported for
-BTX and two associated 13-mer peptides in the asym-the binding of -BTX to the AChR  subunit (Tzartos
metric unit. The final R factor is 20.2%, and R free isand Changeux, 1984). The inhibitory potency of the high
23.5%. The quality parameters of the refined structureaffinity peptides (HAP) is at least two orders of magni-
are listed in Table 2. The Ramachandran plot for thetude better than the inhibition obtained by the original
structure shows no residues in disallowed regions (Fig-phage library lead peptide (Balass et al., 1997), and one
ure 1). The structure contains 217 water molecules. Theorder of magnitude or more better than any synthetic
crystallographic packing produces two kinds of 2-foldpeptide (13–17 residues long) corresponding to se-
related dimers. The crystallographic dimer of monomersquences from the -BTX binding site of AChR (Table 1).
A–A displays a continuous sheet area across the 2-foldIn the present study, we have determined the crystal
axis perpendicular to the  strands, similar to the onestructure of the complex formed between one HAP
seen in the X-ray structure of -BTX (Protein Data Bank(WRYYESSLLPYPD) and -BTX at 1.8 A˚ resolution. This
ID code 2abx) (Love and Stroud, 1986), even though theHAP differs from the library lead peptide by only three
unit cell and space group are different. In this dimer,residues; however, this difference causes an increase
the two HAP peptides are situated far apart (ca. 40 A˚)in its binding to -BTX, by more than two orders of
from each other (Figure 2a). The crystallographic dimermagnitude. We have demonstrated that this HAP fits
of monomers B–B has a 2-fold axis in the plane of thesnugly to the toxin, making numerous interactions with
 strands (Figure 2b). The two monomers, with theirthree of its fingers. It assumes a loop conformation, with
associated HAPs, were refined independently. The RMS
two  strand sections, one of which makes a  sheet
deviation of the C’s of the -BTX monomers A and B
with an -BTX strand. The structural data can be used is 0.64 A˚ (using all 74 residues) and of the HAPs associ-
for the design of peptide ligands having a desired highly ated with monomers A and B (using 12 residues of the
specific biological activity and contribute to resolving HAP) is 0.68 A˚ (Table 3). Differences larger than 1.2 A˚
the fine structure of the AChR ligand binding site in are seen in three loops of the two independent -BTX
general. The structure of the peptide and the homolo- molecules. The two HAPs show a large C difference
gous loop of the AChBP, a soluble analog of the extracel- (1.5 A˚) only in their N-terminal Trp position. The mono-
lular domain of the acetylcholine receptor, are remark- mers show surprising differences in their average tem-
ably similar. From this it was possible to construct a perature factors, 22.2 A˚2 for -BTX monomer A, and
detailed model of the interaction of -BTX with the pen- 27.7 A˚2 for monomer B. Monomer A also displays signif-
tameric AChBP, and by analogy, to see the interaction icantly more residues with alternate conformation (see
of -BTX with the AChR. The toxin is seen to wrap below), and all 13 residues in its associated HAP can
around the receptor binding site loop, and in addition, be seen, but only 12 in monomer B complex. The higher
to bind tightly, in an interlocking fashion, at the interface degree of order in monomer A may be due to its crystal
of two of the receptor subunits where it inserts a finger packing environment. Monomer A, together with its as-
into the ligand binding site. This reveals how the toxin sociated HAP, has 96 packing contacts (shorter than
blocks access to the acetylcholine binding site and thus 3.6 A˚) to symmetry-related molecules, while monomer
B has only 50 such contacts. Dynamic light scatteringexplains its strong antagonistic activity.
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Figure 1. Ramachandran Plot for -BTX-HAP
The plot was produced by PROCHECK
(Laskowski et al., 1993).
measurements on a complex between -BTX and a pep- Interactions of the HAP with -BTX
The 13-mer HAP assumes an antiparallel  hairpin struc-tide corresponding to residues 182–202 of Torpedo
AChR  subunit have shown it to be monomeric at pH ture, and is held snugly between fingers 1, 2, and 4 of
-BTX (see Figures 2 and 3). Out of a total of 1,552 A˚25.0 and dimeric at higher pH values (Samson et al., 2001).
Since the crystal was grown at pH 7.5, it is possible that of accessible surface area of HAP A, ca. 45% (682 A˚2)
becomes inaccessible upon its binding to -BTX (Figuredimer of monomer A (Figure 2a), which is similar to the
-BTX dimer seen in the published structure (Protein 3). The shortest and most numerous interactions are
formed with finger 2 of -BTX. The two arms of the HAPData Bank ID code 2abx), is present in solution.
hairpin assume a  sheet conformation, with residues
Arg188-Tyr190 making an intermolecular interaction
with -BTX residues Val39-Glu41, and residues Leu195-
Table 2. Crystallographic Data for -BTX-HAP Complex
Tyr197 making an intramolecular interaction with
-BTX-HAP Arg188-Tyr190. The short intramolecular interactions in
-BTX-HAP KI Soak the two copies of the HAP are listed in Table 4. Similar
Unit cell (A˚) 42.0, 153.4, 73.0 41.9, 151.5, 72.8 interactions have been recently demonstrated in an
Resolution range (A˚) 40–2.4 23.5–1.8 NMR study of the structure of a complex of -BTX with
Number of unique reflections 9,611 22,265 another high affinity peptide (HAP#2 in Table 1) (Scherf
Completeness (%) 99.5 (95.9)a 99.0 (99.1)a
et al., 2001). Moreover, the NMR structure of a complexRsym (on I) (%) 11.6 (43.9)a 8.1 (59.4)a
of -BTX with a library lead peptide differing by onlyI/(I) 12.7 (2.6)a 14.0 (2.3)a
three residues from the one studied here (Scherf et al.,Number of protein atoms 1,334
Number of solvent atoms 217 1997) (Table 1) also shows a similar fold to the HAP and
Number of iodine atoms 2 a similar binding site to -BTX. However, in this case,
Rfact (Rfree) F  0 20.2% (23.5%) the X-ray and NMR structures show some deviation
RMS from idealityb
(Table 3) mainly in the loop regions and the C termini.Bond length (A˚) 0.005
An NMR study (Samson et al., 2001) of the structure ofBond angle () 1.5
the complex of -BTX and a peptide corresponding toRamachandran plotc
Favored 92.1% residues 182–202 of TcAChR showed that peptide to
Allowed 7.9% have also a  hairpin conformation with 2 short  sheet
Generously allowed 0.0% segments. However, that NMR structure shows a longer
Disallowed 0.0% turn region with residues His186-Val188 and Tyr198-
a Statistics for outer shell 1.86–1.80 A˚ data in parentheses. Asp200 of the peptide having the  sheet conformation,
b Calculated by module xtal_pdbsubmission of program CNS and the intermolecular interaction is with -BTX resi-
(Bru¨nger et al., 1998). dues Lys38-Val40. Surprisingly, a recent study on the
c Calculated by program PROCHECK (Laskowski et al., 1993).
NMR solution structure of a complex of -BTX and a
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Figure 2. The Crystallographic Packing of
the -BTX-HAP in the Crystal Produces Two
Kinds of Dimers
(a) Monomer A makes a 2-fold related dimer
with a continuous  sheet area across the
2-fold axis which is perpendicular to the plane
of the  strands, like the one seen in the
-BTX X-ray structure (Protein Data Bank ID
code 2abx) with the two HAPs situated far
apart (ca. 40 A˚) from each other. (b) Dimer
produced by monomer B by a 2-fold axis
which lies in the plane of the  strands. The
two HAPs are likewise far apart.
peptide corresponding to residues 181–198 of muscle (Pro10-Ser193), 12.72 A˚ (Cys33-Ser193), 14.45 A˚ (Pro10-
Ser192), 9.76 A˚ (Cys33-Ser192), respectively.type AChR did not demonstrate a  hairpin structure
(Zeng et al., 2001). This could be due to the fact that The HAP was found to inhibit -BTX binding to
TcAChR with IC50 of 1.9  109 M while a peptide corre-only 11 intermolecular interactions were observed in
that study. A previous NMR study of-BTX complex with sponding to the sequence 187–200 of TcAChR inhibited
the binding with IC50 of 2.6 108M (Kasher et al., 2001),a dodecapeptide corresponding to residues 185–196 of
the TcAChR  subunit (Basus et al., 1993) revealed that i.e., one order of magnitude weaker. This may be ex-
plained by the gain of four H bonds in the tightly bindingthe bound peptide adopts an extended conformation,
and interactions with -BTX were formed only between N terminus of the HAP, i.e., in residues Arg188, Glu191,
and Ser192 (Table 5), which are Val, Thr, and Cys in thea peptide segment corresponding to residues 186–190
of the receptor. Affinity labeling experiments which iden- TcAChR sequence.
As demonstrated in Figure 4, Tyr189 of the HAP formstified positions 10 and 33 of -neurotoxin to be within
11.5–15.5 A˚ from AChR residues Cys192-Cys193 (Mi- a snug fit into a loop region of -BTX. The formation of
two H bonds from its hydroxyl to residues Thr8 and Ile11chalet et al., 2000) agree with the -BTX-HAP structure
where the corresponding C distances are 11.05 A˚ of -BTX (Table 5) makes the tyrosine at that position
Table 3. RMS Deviation of C Positions in A˚
Monomer A Number residues used
Monomer B 0.64 74
NMR -BTX structure (PDB ID code 2btx) 4.03 74
Monomer A of -BTX (PDB ID code 2 abx) 4.03 74
Neurotoxin-I (PDB ID code 1 ntn) 0.76 63
HAP A
HAP B 0.68 12
NMR lead peptide (PDB ID code 2btx) 2.15 13
ACh binding loop 182–193 of AChBP 0.76 12
Structure of the Binding Site of AChR
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Figure 3. 3D Surface Drawing of the Structure of -BTX-HAP
Color of the -BTX corresponds to electrostatic charge, with blue positive and red negative (rendered with WebLabViewerLite software (MSI,
1998).
(a) -BTX-HAP monomer A complex. HAP is shown in green.
(b) -BTX monomer A with HAP removed.
an ideal candidate for forming binding interactions with or in the corresponding 1 and 7 peptides prohibits
them from binding -BTX (Balass et al., 1997).-BTX. Indeed, this tyrosine is known to play a crucial
role in -BTX binding. Muscle (1) or neuronal (7)
AChRs that bind -BTX all have a Tyr, or sometimes
What Makes HAP a Stronger Binding Peptide?
Phe, at position 189. It should be noted that there are
Substitution of three residues in the sequence of the
no significant differences in the binding properties of
lead peptide resulted in a high affinity peptide (HAP)
AChRs containing Tyr or Phe at position 189. However,
with an increase of 2 orders of magnitude in its affinity
replacement of Tyr189 with Phe in the library lead pep-
to -BTX (Kasher et al., 2001). Can our X-ray structure
tide resulted in lowering the binding potency by one
provide explanation for this enhanced affinity? Putting
order of magnitude (Kasher et al., 2001). Muscle AChRs
Trp at the N terminus of the peptide (in position 187)
from animal species that are resistant to -BTX (e.g.
adds 2 side chain interactions of the HAP with the toxin,
snake and mongoose) or neuronal AChRs that do not
between the indole NE atom and the carbonyl oxygens
bind -BTX have a nonaromatic residue at this position
of residues 6 and 7 of -BTX (Table 5). Indeed, residue
(Barchan et al., 1995). Neuronal AChR subunits 2, 3,
187 is a Trp in the 1 subunit of TcAChR.
and4 have Lys at this position. The receptor complexes
The substitution of Ser196Pro adds to the stability of
containing these subunits do not bind -BTX. In con-
the binding conformation of the peptide. Proline at this
trast, the neuronal receptor containing 7, which has a
position is found in AChR sequences (196 in the 7 and
Tyr at this position, does bind-BTX. The X-ray structure
the homologous 197 in 1). The proline fits well in a
shows that Tyr189 cannot be changed to Lys without
hydrophobic pocket. It is situated at the core of the
clashes in the -BTX binding cavity. This explains the
HAP’s intramolecular  sheet, and makes stacking inter-
resistance of neuronal 2, 3, and 4 AChRs to -BTX.
actions with Tyr189 and edge-on interactions with
This is also supported by our previous findings demon-
Trp187. The X-ray structure does not explain the benefit
strating that the mutation Tyr189Lys in the lead peptide
of the Lys195Leu substitution. A peptide with Lys in
position 195 showed also a tighter binding to -BTX
(Table 1).Table 4. Short Intramolecular Distances (3.3 A˚) in HAP
HAP Residue Atom HAP Residue Atom Distance (A˚)a
Some Surprises Provided by the 1.8 A˚ StructureArg188 N Asp199 OXT 3.26 ()
Ten residues in the refined structure show alternate con-Arg188 N Tyr197 O 2.84 (6.37)
formations. These are Ser12, Ala31, Cys48, Ser50,Arg188 O Tyr197 N 2.71 (2.88)
Tyr190 O Ser193 N 3.21 (3.29) Glu56, and Cys59 in -BTX of monomer A and Ser34,
Tyr190 O Ser192 N 3.00 (3.19) Glu56, and Gln71 in monomer B. Since the two mono-
Ser193 OG Leu195 N 2.94 (2.96) mers and two HAPs in the asymmetric unit were refined
Ser193 OG Leu194 N 2.94 (2.67)
independently (i.e., no noncrystallographic symmetryPro198 O Asp199 OXT 3.00 ()
applied; Table 3), the fact that different residues show
a Numbers in parenthesis represent distances in independently re- alternate conformations in the two monomers reflects
fined HAP B.
the different environments in which these residues are
Neuron
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Table 5. Short Intermoleuclar Distances between HAP and -BTX
HAP Residue Atom -BTX Residue Atom Distance (A˚)a
Trp187 NE1 Thr6 O 3.35 (4.96)
Trp187 NE1 Ala7 O 3.80 (3.45)
Trp187 N Thr6 O 6.81 (2.90)
Arg188 NH1 Asp30 OD2 3.13 (3.37)
Tyr189 OH Thr8 O 2.70 (2.59)
Tyr189 OH Ile11 N 3.35 (3.43)
Tyr189 O Val40 N 2.86 (2.77)
Tyr190 OH Asp30 OD2 2.49 (2.55)
Tyr190 O His68 NE2 2.89 (2.82)
Glu191 OE1 Lys38 N 2.73 (2.70)
Glu191 N Lys38 O 2.92 (2.91)
Ser192 OG Arg36 O 2.72 (2.67)
Ser192 N Arg36 O 3.32 (3.22)
Ser193 O His68 NE2 3.15 (3.09)
Leu194 CD2 Gln71 NE2 3.02 (3.26)
Tyr197 CZ Arg36 CD 3.89 (3.79)
a Numbers in parenthesis represent distances from independently refined monomer B.
located in the crystal. Some of these alternate conforma- (Sigma cat. No. T3019) has shown the presence of the
two species of -BTX and enabled their separation. Thetions are of particular interest.
The S-S bond formed by residues Cys48 and Cys59 two species do not show any difference in binding to
TcAChR (M. Balass, personal communication), or in theirshows alternate conformations with SG having a dihe-
dral angle 	 ca. 120 between two conformations. Each tendency to crystallize. Indeed, the X-ray structure
shows residue Ala31 to be pointing into the solution,of these bonds is populated by ca. 50% of the residues.
This alternate S-S bond is seen only in one of the two away from the HAP binding surfaces. The structure of
monomer A shows alternate -BTX molecules with ca.independently refined monomers (monomer A).
In the NMR structure determination of -BTX com- 30% having Val31 in the Ala31 position.
The crystal which underwent a quick dip in a 0.3 Mplexed with TcAChR peptide 185–196 (Basus et al.,
1993), residue Ala31 was reported to be Val in some KI containing solution before data collection yielded
data to much higher resolution (1.8 A˚) compared to theof the -BTX population. HPLC analysis of the -BTX
Figure 4. The Snug Fit of Tyr189 of the HAP (Cyan) into a Loop Region of -BTX (Yellow)
Short interactions shown as dashed lines. Water molecules shown in magenta. The composite omit map (Bru¨nger et al., 1998) is drawn at 1.7.
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Figure 5. Comparison, in Stereo, of the 3D Structures of HAP (Red) and Loop 182–193 of AChBP (Blue)
Only main chain and C atoms are shown for clarity.
nonsoaked crystal (2.4 A˚), yet the position of the iodine tives. It is possible that a slightly longer soak (3 min
soak was tried) could yield an effective derivative, andatom could not be located by difference Fourier meth-
ods (see Experimental Procedures section). When the this method (Dauter et al., 2000) looks very promising
either as a quick way to obtain heavy atom derivativesstructure was refined, two solvent molecules were found
to have high residual Fo-Fc density, and their temperature or better diffracting crystals.
factors refined to the minimum value allowed by the
program. Subsequently, these two molecules were re- The Binding of -BTX to AChR
Recently, the structure of acetylcholine binding proteinfined as partially occupied (40%) iodine ions, resulting in
no residual difference density and average temperature (AChBP) has been determined at 2.7 A˚ resolution (Brejc
et al., 2001). The AChBP modulates synaptic transmis-factors. Both iodine atoms are located in a pocket
formed by Arg25, Met27, Glu56, and Thr58 of monomers sion and its sequence is 28.2% identical to that of the
extracellular domain of AChR 7 subunit. AChBP bindsA and B. The partial occupancy of the iodine atoms
explains the difficulty in locating them in a difference acetylcholine and antagonists like -BTX (Smit et al.,
2001). The AChBP crystal structure shows it to be aFourier map and hence the preclusion of their use for
providing phasing information as heavy atom deriva- pentamer like the AChR molecule. The ACh binding site
Figure 6. A Stereo View of the Combined Model of -BTX-HAP (Red) and AChBP Structure with Subunit A in Green and Subunit B in Yellow
Showing the Insertion of Loop 2 of the Toxin into the Interface of the Two Subunits
The positively charged HEPES molecule (black stick figure) shows the location of the acetylcholine binding site and the blockage of passage
to this site caused by the binding of the toxin. The HAP, which overlaps the 182–193 loop of AChBP, is shown in blue.
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Figure 7. The Combined Model of the AChBP Pentamer with Five Copies of -BTX (Red) Bound to It, as Viewed down the 5-Fold Axis of the
Pentamer
in AChBP was assigned by the localization of a solvent not perfect, there are, in fact, no interactions shorter
than 3 A˚ between main chain atoms of -BTX and thosemolecule (positively charged HEPES) seen near residues
corresponding to the 187–199 loop of the AChR  sub- of the two AChBP subunits with which it interacts. Early
crosslinking studies (Karlin et al., 1979; Oswald andunit and stacking on the corresponding Trp143 . The
AChBP structure is obviously an ideal candidate for test- Changeux, 1982) have already indicated that -BTX
crosslinks not only to the  subunit, but also to the 
ing the relevance of the conformation of the HAP when
bound to -BTX, to that of the corresponding binding and  subunit, and support the notion that it binds to

 and  interfaces. Upon binding of -BTX to theregion in AChR. The overlay of the first 12 residues of
the 13-mer HAP on AChBP residues 182–193 shows the AChBP pentamer in the superposition model, 18%
(760 A˚2) of the toxin surface becomes inaccessible. ItHAP to assume exactly the same conformation as the
AChBP loop, and hence probably that of the -BTX is noteworthy that in this superposition, -BTX binds
perpendicular to the 5-fold axis of the AChBP molecule,(ACh) binding loop in AChR (Figure 5). Although the
sequence of HAP has only three identical residues to and therefore, there are no steric hindrance limitations
even when five toxin molecules bind to AChBP (Fig-the 182–194 loop of AChBP (Table 1), the RMS of C
for the 12 residues is just 0.76 A˚. It thus seems that ure 7).
As is evident from the X-ray structure, the major inter-even the short 13-mer binding HAP assumes a structure
similar to the corresponding region of AChR upon bind- actions between -BTX and the HAP, and by the analogy
to the AChR  subunit, occur in residues 187–192 ofing to -BTX.
The superposition of the HAP on loop 182–193 of that subunit. These interactions are listed in Table 5 and
shown in Figure 4. The interactions agree with severalAChBP reveals the -BTX to fit exquisitely into the inter-
face of two subunits of the pentameric AChBP (Figures studies aimed at locating the -BTX binding domain on
the  subunit of AChR (Aronheim et al., 1988; Conti-6 and 7). Hence, not only does the 182–193 stretch of
the AChBP subunit make contacts with fingers 1, 2, Tronconi et al., 1990; Neumann et al., 1986b; Ralston et
al., 1987; Wilson et al., 1985, 1988; Wilson and Lentz,and 4 of -BTX as is seen in the -BTX-HAP complex
(Figures 2 and 3), but in addition, loop 2 of the toxin is 1988). Mutational studies of the long chain -cobratoxin
have identified residues 28, 30, 32, 36, 39, and 68 (-BTXinserted into the interface of two adjacent subunits of
AChBP with relatively minor clashes between AChBP numbering) as involved with binding of the toxin to both
neuronal and muscle AChR (Antil-Delbeke et al., 2000).and -BTX. It is noteworthy that although the model is
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dissolved in dimethylformamide for 20–45 min at room temperature.In our X-ray derived model, these residues are all near
Cleavage of the peptide from the polymer was performed by reactingthe AChBP with nearest C-C distance of 5.2, 5.4, 4.4,
the resin of each reaction vessel with 1.8 ml trifluoro-acetic acid6.2, 4.9, and 6.4 A˚, respectively.
(TFA)/H2O/thioanisole/ethane-dithiol/phenol at volume ratios ofThe superimposed model of AChBP and-BTX shows 87.5/5/5/2.5/trace amount, for 2 hr at room temperature. The cleav-
residues 34–36 (corresponding to residues 36–38 of age mixtures were cooled to 4C; the peptides were precipitated
with ice-cold di-tert-butylether and centrifuged for 10–15 min, 3000AChR  subunit) and 162–165 (181–184) of the neigh-
rpm at 4C. The pellet was washed and centrifuged three times withboring AChBP subunit (subunit B) as abutting the -BTX
di-tert-butylether, dissolved in water, and lyophilized. The HPLC-molecule. Selective point mutations of the 
 and  AChR
purified HAP was analyzed by time-of-flight mass spectrometry us-subunits, followed by agonists’ binding studies to the
ing a VG MALDI TOF mass spectrometer (VG Fisons, Altrincham,
resulting AChR mutants, were previously used in order UK), and was found to exhibit 1689.7 mass units (calculated 1688.9).
to identify and localize the agonists’ binding sites on
these subunits. Such studies have identified Asp180 HAP Purification and Analysis by Reversed-Phase HPLC
or the aligned 
Asp174 (Martin et al., 1996), as well as The synthetic HAP was purified by using a prepacked LiChroCart
RP-18 column (10  250 mm, 7 m bead size; Merck, Darmstadt,Ser36 or 
Lys34 and Ile178 or 
Phe172 (Prince and
Germany) employing a binary gradient formed from 0.1% TFA inSine, 1996), as part of the ACh binding site in AChR, in
water (solution A) and 0.1% TFA in 75% acetonitrile in water (solutionaddition to the major binding loop in the  subunit. All
B). The chromatographic run (flow rate 5.0 ml/min) started with 20%
these residues are at, or in very close proximity to, the solution B in solution A, kept constant for 15 min, followed by a
site in the B subunit of AChBP that interacts with -BTX. gradient increase of solution B from 20% to 60% over an additional
Moreover, this is in agreement with recent studies show- 35 min. The peak was eluted at 37 min. Peptide purification was
performed using a Spectra-Physics SP8800 liquid chromatographying that loop 2 of -neurotoxins interacts with amino
system equipped with SP8500 dynamic mixer and an Applied Bio-acid residues from the 
, , and  subunits, located at
systems 757 variable wavelength absorbance detector. The chro-the interface of the  subunit (Malany et al., 2000; Osaka
matograms were recorded on a Chrom-Jet integrator.
et al., 1999, 2000; Sine, 1997). This adds additional Purity validation of the synthetic HAP was performed by analytical
weight to the similarity in the ligand binding manner, reversed-phase HPLC, using a pre-packed Lichrospher-100 RP-18
and 3D structure, of the AChBP pentamer to that of the column (4  250 mm, 5 m bead size; Merck, Darmstadt, Germany)
and the same buffer system as described above, except that theAChR pentamer.
gradient started with 5% solution B (flow rate 0.8 ml/min), keptIt is noteworthy that residue Lys38 of -BTX is near
constant for 5 min, and then increased solution B from 5% to 95%Asp161 of AChBP subunit B, i.e., the homologous AChR
over 40 min. The purified HAP eluted at 27.5 min and was 99%
Asp180 or
Asp174 identified as part of the ACh binding pure. The chromatographic analysis was performed using a Spectra-
site (Martin et al., 1996). The possible formation of an Physics P200 liquid chromatography system equipped with a Spec-
intermolecular salt bridge between AChR and -BTX at tra-Physics UV100 variable wavelength absorbance detector and
AS100 auto sampler. The chromatograms were recorded on a PEthat position may provide further explanation to the high
Nelson integrator model 1022. All column effluents were monitoredaffinity of binding of the toxin to the receptor. This notion
by UV absorbance at 220 nm; solvents were obtained from Merckis supported by recent studies on charge reversal muta-
(Darmstadt, Germany).
tions of basic residues on loop 2 of -neurotoxin (Osaka
et al., 2000). These studies indicate electrostatic interac- Preparation of -BTX-HAP Complex
tions between the toxin and the 
, , and  subunits of A solution of the purified HAP (10 mg/ml water, adjusted to pH 7
AChR. The superimposed model of AChBP and -BTX with 0.5 N NaOH and 0.2 N HCl) was mixed with a solution of -BTX
from the snake venom of Bungarus multicinctus (Sigma, productsuggests that the putative agonist HEPES seen in the
number T3019; 10 mg/ml water) at a volume ratio of 1:3.3, respec-AChBP structure is blocked from entering or leaving the
tively, to give a molar ratio of 1.5:1 HAP:-BTX. The resulting solutionAChBP interface cleft by the insertion of loop 2 of -BTX
(measured pH 7) was incubated overnight at 4C for complex forma-
into that cleft (Figure 6). This clarifies and explains the tion, centrifuged (5 min, 14000 rpm), and was used for crystallization.
strong inhibition of AChR function by the toxin. -BTX-HAP crystals were grown by the hanging drop method at
19C from a solution containing 10 mg/ml of the complex. This
solution was diluted at the ratio of 3:1 with the reservoir solution,Experimental Procedures
whose composition was 40% polyethylene glycol 3350, 0.1 M PIPES
buffer pH 7.5. Crystals grew in 3 days as rectangular prisms, 0.3 Synthesis of the HAP
0.1  0.1 mm in size, space group C2221.All protected amino acids and coupling reagents were purchased
from Novabiochem (Laufelfingen, Switzerland). Solvents for peptide
synthesis were of synthesis-grade (Labscan; Dublin, Ireland). HAP Data collection, Structure Determination, and Refinement
X-ray data to 2.4 A˚ resolution (Table 2) were collected on an R-AXIS-was prepared by conventional solid-phase peptide synthesis, using
a few reaction vessels of an ABIMED AMS-422 automated solid- II detector at 100 K, from a single crystal that had been dipped in oil.
Attempts at solving the crystal structure by molecular replacementphase multiple peptide synthesizer (Langenfeld, Germany). The
9-fluorenylmethoxycarbonyl (Fmoc) strategy was used throughout (AMoRe program (Navaza, 1994)) using as starting model either the
X-ray structure of -BTX (Protein Data Bank code 2abx; Love andthe peptide chain assembly (Atherton and Sheppard, 1989), follow-
ing the company’s commercial protocols. Wang resin, which con- Stroud, 1986) or the NMR structure of -BTX-lead peptide complex
(Protein Data Bank code 2btx; Scherf et al., 1997) produced verytains 25 mol of a covalently bound N-Fmoc aspartic acid (the
first C-terminal residue), was used in each reaction vessel (polymer low peaks with poor correlation, and all the solutions showed severe
clashes with symmetry-related molecules. In an effort to get a suit-loading of 0.55 mmol/g). Side chain protecting groups were tert-
butyloxycarbonyl (t-Boc) for Lys; tert-butyl-ester (O-t-But) for Asp able heavy atom derivative, we used the method developed by
Dauter which uses quick soaking of a crystal in mother liquor con-and Glu; tert-butyl ether (t-But) for Ser and Tyr; and pentamethyldi-
hydrobenzofuran-5-sulfonyl (Pbf) for Arg. Coupling was carried out taining halides such as Br or I (Dauter et al., 2000). An -BTX-HAP
crystal was soaked in mother liquor solution containing 0.3 M KI forby using two successive reactions with 100 mol (4 equiv.) of the
corresponding N-Fmoc amino acid, 100 mol (4 equiv.) of benzotri- 3 min, then transferred to oil and flash cooled. This crystal diffracted
to a much higher resolution, i.e., 1.8 A˚ (Table 2), but the iodineazole-1-yl-oxy-tris-pyrolidino-phosphonium hexafluorophosphate
(PyBop) reagent, and 200 mol (8 equiv.) of 4-methyl-morpholine, all binding sites could not be located using anomalous Patterson or
Neuron
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difference Fourier methods (Results and Discussion section). As binding site of the nicotinic acetylcholine receptor in animal species
resistant to alpha-bungarotoxin. Biochemistry 34, 9172–9176.with the first data set, this higher resolution data set did not yield
a molecular replacement solution. At this stage, we reconsidered the Basus, V.J., Song, G., and Hawrot, E. (1993). NMR solution structure
X-ray structure starting model which was being used for molecular of an alpha-bungarotoxin/nicotinic receptor peptide complex. Bio-
replacement, as this structure, Protein Data Bank ID code 2abx chemistry 32, 12290–12298.
(Love and Stroud, 1986), has a number of outliers in its Ramachan-
Betzel, C., Lange, G., Pal, G.P., Wilson, K.S., Maelicke, A., anddran plot, and appears to be built of nonstandard 3D structural
Saenger, W. (1991). The refined crystal structure of alpha-cobratoxinbuilding blocks (Unger et al., 1989). A FASTA (Pearson, 1990) search
from Naja naja siamensis at 2.4-A resolution. J. Biol. Chem. 266,of sequences similar to -BTX in the Protein Data Bank database
21530–21536.identified two structures as having the highest homology to -BTX.
Brejc, K., van Dijk, W.J., Klaassen, R.V., Schuurmans, M., van derThese are: neurotoxin-I, Protein Data Bank code 1ntn (Mikhailov et
Oost, J., Smit, A.B., and Sixma, T.K. (2001). Crystal structure of anal., 1990) (62.1% identity) and -cobratoxin, Protein Data Bank code
ACh-binding protein reveals the ligand-binding domain of nicotinic2ctx (Betzel et al., 1991) (55.4% identity). The two toxin structures
receptors. Nature 411, 269–276.overlaid reasonably well with the X-ray structure of -BTX (2abx),
but diverged at their C termini. We therefore chose as a search Bru¨nger, A.T., Adams, P.D., Clore, G.M., DeLano, W.L., Gros, P.,
model the first 66 residues of the structure of neurotoxin-I (Protein Grosse-Kunstleve, R.W., Jiang, J.S., Kuszewski, J., Nilges, M.,
Data Bank ID code 1ntn) deleting eight residues from the C terminus. Pannu, N.S., et al. (1998). Crystallography & NMR system: A new
Molecular replacement search was run with program MOLREP software suite for macromolecular structure determination. Acta
(Vagin and Teplyakov, 1997), resulting in a clear peak with R  Cryst. D54, 905–921.
53.9% and correlation 0.277 (the next best peak had values of R Changeux, J.-P., and Edelstein, S.J. (1998). Allosteric receptors after
57.5%, correlation 0.172), and no clashes were observed between 30 years. Neuron 21, 959–980.
symmetry-related molecules. MOLREP yielded coordinates for two
Changeux, J.-P., Kasai, M., and Lee, C.Y. (1970). The use of a snakeindependent monomers in the asymmetric unit.
venom toxin to characterize the cholinergic receptor protein. Proc.The structure was refined with CNS (Bru¨nger et al., 1998), using
Natl. Acad. Sci. USA 67, 1241–1247.the maximum likelihood, slow cooling option. All measured reflec-
Conti-Tronconi, B.M., Tang, F., Diethelm, B.M., Spencer, S.R., Rein-tions were used in the refinement, and the two monomers and two
hardt-Maelicke, S., and Maelicke, A. (1990). Mapping of a cholinergicHAPs were refined independently, i.e., without the application of
binding site by means of synthetic peptides, monoclonal antibodies,noncrystallographic symmetry restraints. The Fobs were scaled an-
and alpha-bungarotoxin. Biochemistry 29, 6221–6230.isotropically and a bulk solvent correction was applied (Bru¨nger et
al., 1998). The structure was fitted into the electron density with the Dauter, Z., Dauter, M., and Rajashankar, K.R. (2000). Novel approach
program O (Jones et al., 1991). The missing C-terminal residues as to phasing proteins: derivatization by short cryo-soaking with ha-
well as an insertion of -BTX residues 13–14 were clearly visible in lides. Acta Cryst. D56, 232–237.
the difference electron density. Density for the HAP peptide was
Jones, T.A., Zou, J.-Y., Cowan, S.W., and Kjeldgaard, M. (1991).
seen, but fitting was complicated by its close proximity to the -BTX
Improved methods for building protein models in electron density
density. The warpNtrace option in program ARP_wARP successfully
maps and the location of errors in these models. Acta Cryst. A47,
traced nine amino acids of one HAP and ten of the other. 116 of
110–119.
the solvent molecules (out of 217) were found by program
Kachalsky, S.G., Jensen, B.S., Barchan, D., and Fuchs, S. (1995).wARP_REFMAC (Perrakis et al., 1997, 1999).
Two subsites in the binding domain of the acetylcholine receptor:
An aromatic subsite and a proline subsite. Proc. Natl. Acad. Sci.Acknowledgments
USA 92, 10801–10805.
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